11630sek
0,6 %
Date:2026-07-27Time:09:41:45Latest report:Q2-2026List:Mid CapTicker:BIOG B
Market Cap:11 795 msekEnterprise Value:11 349 msekNet Sales:1 581 msekEarnings:347,2 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:116,30
MA50:121,83
MA200:112,36
Price/MA200:3,8 %
RSI (14):45,9
Price/MA50:-4,3 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.